Trupanion (NASDAQ:TRUP – Get Free Report) is expected to be issuing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Trupanion to announce earnings of $0.11 per share and revenue of $389.7170 million for the quarter. Investors can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. The company had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.03) earnings per share. On average, analysts expect Trupanion to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Trupanion Stock Performance
Shares of TRUP stock opened at $24.49 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The company’s 50-day moving average price is $24.33 and its 200-day moving average price is $26.40. Trupanion has a twelve month low of $21.16 and a twelve month high of $57.00. The stock has a market cap of $1.07 billion, a price-to-earnings ratio of 41.51 and a beta of 1.39.
Insider Buying and Selling
Hedge Funds Weigh In On Trupanion
Hedge funds and other institutional investors have recently bought and sold shares of the company. Kemnay Advisory Services Inc. purchased a new stake in shares of Trupanion in the fourth quarter valued at approximately $64,000. Kelleher Financial Advisors acquired a new stake in Trupanion in the third quarter valued at $74,000. Advisory Services Network LLC acquired a new stake in Trupanion in the third quarter valued at $160,000. Tidal Investments LLC purchased a new stake in shares of Trupanion during the 2nd quarter worth $212,000. Finally, Renaissance Technologies LLC purchased a new position in shares of Trupanion in the 4th quarter valued at about $224,000.
Wall Street Analyst Weigh In
TRUP has been the topic of a number of research reports. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, June 1st. Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Stifel Nicolaus set a $28.00 price target on Trupanion in a report on Friday, June 26th. Cantor Fitzgerald lowered their price objective on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Finally, Bank of America dropped their price objective on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.60.
Read Our Latest Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Stories
- Five stocks we like better than Trupanion
- Bearish Pressure Is Building Around These 3 Stocks
- 3 Low-Volatility Plays Quietly Making a Name For Themselves
- ASML’s Dividend Growth Adds a Quiet Income Angle to Its AI Chip Story
- 2 Consumer Staples Stocks Giving Investors a Break From the AI Trade
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
